Showing posts with label global Health. Show all posts
Showing posts with label global Health. Show all posts

Sunday, December 07, 2014

The Year Of Spreading Dangerously

image

 

# 9420


In addition to providing the usual scourges of malaria, dengue, seasonal influenza, antibiotic resistant bacteria and pneumonia, 2014 has provided us with a number of new, or sometimes simply transplanted, disease threats around the world.  

 

A reminder that in our highly mobile and interconnected world, a disease threat anywhere can easily become a disease threat everywhere. 

 

The tone for the new year was set during the opening days of January when we saw North America’s first imported case of H5N1 ex-China (see Alberta Canada Reports Fatal (Imported) H5N1 Infection).  During that same week, Hong Kong was dealing with imported cases of H9N2 (link) and H7N9 (link) while Taiwan was dealing with an imported H7N9 infection (see  A Bit More On Taiwan’s Imported H7N9 Case).


Although  these cases were contained they served to remind us how easily a novel flu virus can hop a plane and travel from one country to the next.


The first cases (2 confirmed, 4 probable, 20 suspected) of Chikungunya on the French part of St. Martins were reported in early December of last year, likely imported by a viremic tourist, but by early January it was apparent that the virus was thriving, and spreading across the Caribbean courtesy of a highly competent local mosquito vector.

The ECDC reported as of 9 January 2014:

  • 201 probable or confirmed cases in Saint Martin (FR);
  • 2 confirmed cases in Saint Martin (NL);
  • 48 probable or confirmed cases in Martinique;
  • 25 probable or confirmed cases in Saint Barthélemy;
  • 10 probable or confirmed cases including one imported case from Saint Martin in Guadeloupe;
  • 1 confirmed case imported from Martinique in French Guiana.

 

Within weeks there would be thousands of cases, and within months hundreds of thousands. From these humble beginnings, in less than a year, the latest PAHO surveillance report (December 5th, 2014) puts the number who have been infected in the Americas now at just under 1 million people – although that is likely an undercount.


Of some solace, while painful and sometimes debilitating, Chikungunya has a fairly low mortality rate.  Still hundreds have died, and thousands have suffered long-term disability due to the virus. 

 

Although there have only been 11 locally acquired cases in the continental United States (all in Florida), this year more than 1,900 visitors have tested positive for the virus, increasing the odds that CHKV will eventually take up residence in North America.  

 

We’ve seen similar expansion of Dengue this year, with major new outbreaks in China and Japan.

 

While we were watching  the second wave of H7N9 accelerate in China, on January 17th we learned of the first outbreak of a new subtype of avian flu; H5N8 (see Media Reporting Korean Poultry Outbreak Due To H5N8) – which over the next several months would result in the culling of more than 13 million birds.

 

Currently only a threat to poultry, this virus has – over the first 11 months – spread as far east as Japan and as far west as the UK, likely carried by migratory birds.  Where it shows up next is anyone’s guess.

image

H5N8 Branching Out To Europe & Japan

 

Adding complexity to last winter’s bird flu season, we also saw three human infections with a new H10N8 virus (see Jiangxi Province Reports Second H10N8 Infection), and later in the spring, with a never-before-seen HPAI H5N6 virus (see Sichuan China: 1st Known Human Infection With H5N6 Avian Flu).


Both are wild cards for the upcoming winter season, but will have to be watched carefully for further spread.  H5N6, in particular, has been widely reported in poultry across both China and Vietnam in recent months.


And while H7N9 set worrisome new records for human infections during its second wave (n=322 cases vs 134 cases) last winter and spring, on the Arabian Peninsula MERS was also setting new records, and expanding its geographic range as well. 

 

The United States saw two imported cases last May, but it wasn’t alone, as more than a dozen nations have seen imported cases from the Middle East. With a distinct seasonal pattern, we can probably expect another surge in MERS cases after the new year.

image

image

Credit BCCDC

 

And while bird flu and MERS kept us busy during the first half of 2014, since the summer the first regional epidemic of Ebola – and in an area (West Africa) where it had never previously sparked an outbreak – became the big infectious disease threat of the year. 

 

With at least 17,000 infected (estimates range up to 2.5x’s official counts) and more than 6,000 dead, this Ebola outbreak continues to re-write the rules of how Ebola is expected to behave. 

image

Credit WHO Roadmap Dec 3rd.


While the effect of this epidemic on nations in western Africa has been nothing less than devastating, so far the impact from exported cases to the United States and Europe has been fairly limited.  It has, however, necessitated the creation of an extensive and expensive surveillance and reporting system here in the U.S., and around the globe.


A far lesser threat, here is the United States we saw an outbreak of a rarely-seen non-polio enterovirus (EV-D68) starting last August -first reported in Kansas City - but quickly spreading across the nation.  While most only saw mild illness, at the same time we saw  a few dozen children experience a rare form of paralysis thought to be linked to the virus (see CIDRAP: Likely That Polio-like Illness & EV-D68 Are Linked).

 

There were others, of course.  One off’s like the imported case of Lassa Fever in Minneapolis, MN and an imported case of CCHF (ex-Bulgaria) to the UK. 

 

Like embers drifting from a distant fire, most of the time these disease introductions burn out without harm, but they nonetheless harbor some potential to ignite where ever they land.

 

The reality of life in this second decade of this new century is that disease threats that once were local, can now spread globally in a matter of hours or days, thanks to our highly mobile society. 

 


And as our population and mobility have grown, so have the number of emerging infectious disease threats.  Something that was foretold two decades ago by anthropologist and researcher George Armelagos of Emory University, which I described in considerable detail in The Third Epidemiological Transition.

 

Earlier this year, we looked at an assessment by the Director Of National Intelligence who includes emerging infectious diseases and  Influenza Pandemic As A National Security Threat. 

From that report:

Worldwide Threats Assessment – published January 29th, 2014,

(Excerpt)

Health security threats arise unpredictably from at least five sources: 

  • the emergence and spread of new or reemerging microbes;
  • the globalization of travel and the food supply;
  • the rise of drug-resistant pathogens;
  • the acceleration of biological science capabilities and the risk that these capabilities might cause inadvertent or intentional release of pathogens; and
  • adversaries’ acquisition, development, and use of weaponized agents. 

Infectious diseases, whether naturally caused, intentionally produced, or accidentally released, are still among the foremost health security threats.  A more crowded and interconnected world is increasing the opportunities for human, animal, or zoonotic diseases to emerge and spread globally.  Antibiotic drug resistance is an increasing threat to global health security.  Seventy percent of known bacteria have now acquired resistance to at least one antibiotic, threatening a return to the pre-antibiotic era.


While we’ve heard the warnings for years, 2014 seems to have accented the message; global health security is truly a national security issue.

 

The obvious hotspots to watch right now center around China, Africa and the Middle East, but the 2009 H1N1 pandemic and this year’s EV-D68 outbreak show that our own backyard can be a fertile viral proving ground as well.

 

The rise or emergence of disease threats like  MERS-CoV, H5N1, Nipah, Hendra, Lyme Disease, Ebola, H7N9, H10N8, H5N8, H5N6, NDM-1, CRE, etc. doesn’t appear to be a temporary aberration – but rather an ongoing trend - and so we need to be thinking about our local and global response to these threats.

 

And while you and I may not be able to do much personally about the international health response, we can ensure our families, friends, and businesses are better prepared to deal with whatever comes down the pike next.

 

Some earlier blogs on pandemic preparedness you may find worth re-visiting include:

 

MMWR: Updated Preparedness and Response Framework for Influenza Pandemics
It’s Not Just Ebola
NPM14: Because Pandemics Happen
Pandemic Planning For Business

 

Because,  if what’s past is prologue, then 2015 could prove to be an even more challenging year when it comes to the emergence and expansion of infectious disease threats around the world.  

Friday, July 04, 2014

UK PHE Reports Imported Case Of CCHF

image

Photo Credit- CDC

 

# 8805

 

A recurring theme in public health is just how quickly, and easily, that `exotic’ diseases can cross vast oceans or borders, given our modern air travel industry and our penchant for international travel (see The Global Reach Of Infectious Disease). 

 

The introduction of Chikungunya to the Caribbean last fall, and the ensuing (and ongoing) epidemic, are almost certainly the result of an infected traveler coming from an endemic region of the world.

 

Similarly the reintroduction of Dengue to South Florida in 2009, and the arrival of West Nile Virus in New York in 1999, are both thought to have arrived via infected international travelers, and both (probably after multiple introductions) have managed to gain a foothold in the United States.

 

More dramatically, but with less public health impact, earlier this year we saw the first North American importation of H5N in a nurse returning from China (see H5N1 In Canada: A Matter Of Import), while a few months later we saw Minnesota: Rare Imported Case Of Lassa Fever.

 

The good news is - despite their fearsome reputations - neither of these two diseases are easily spread between humans, and no secondary infections were reported.

 

The continual importation of measles has seen us go from the near-elimination of the virus in this country in 2000 to this year’s CDC Telebriefing: Worst US Measles Outbreak In 20 YearsAnd the most recent Arbovirus surveillance report lists thus far for 2014  the detection of 24 imported cases of Dengue, 52 imported cases of Chikungunya, and 20 imported cases of Malaria . . . in Florida alone.


Given this track record, no one should be terribly surprised to learn that the Public Health England reported yesterday their second known case of imported CCHF (Crimean-Congo Hemorrhagic Fever).   While CCHF can be transmitted from one human to another, it requires contact with infected blood or bodily fluids, and so it isn’t easily done.

 

 

Crimean-Congo haemorrhagic fever case identified in UK

From: Public Health England

History: Published 3 July 2014

Part of: Public health

PHE is aware of a laboratory-confirmed case of CCHF in a UK traveller who was bitten by a tick while on holiday in Bulgaria.

PHE sign

The patient is responding well to treatment and there is no risk to the general population.

As a precautionary measure, close contacts of the patient, including hospital staff involved in the patient’s care, will be given health advice and encouraged to contact their GP if they experience symptoms.

Although Crimean-Congo haemorrhagic fever (CCHF) can be acquired from an infected person, this would require direct contact with their blood or body fluids and the risk even for close contacts is considered very low.

This is the second laboratory-confirmed case of CCHF in the UK, following the diagnosis in 2012 of CCHF in a UK resident who had recently returned from Afghanistan.

CCHF is the commonest viral haemorrhagic fever worldwide. It is not found in the UK but is endemic in many countries in Africa, the Middle East, Asia and Eastern Europe, including Turkey and Bulgaria.

People most at risk are agricultural workers, healthcare workers and military personnel deployed to endemic areas. CCHF is most often transmitted by a tick bite but can also be spread through contact with infected patients or animals.

Dr Tim Brooks, Head of Public Health England’s (PHE’s) Rare and Imported Pathogens Laboratory (RIPL) said:

It’s extremely rare to see a case of Crimean-Congo haemorrhagic fever in the UK, and it’s important to note there is no risk to the general population. As a precaution, close contacts of the patient will be contacted and monitored, but the risk of transmission is very low and would require direct contact with bodily fluids.

 

 

The first imported case of CCHF in the UK, mentioned above, was a 38-year old man who flew into Glasgow, Scotland from the Middle East (see Update: CCHF Patient In Scotland Dies).

 

While uncommon in Western Europe, this tickborne virus is widely distributed across parts of Eastern Europe, the former Soviet Union, the Mediterranean, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.

image

Credit WHO

 

CCHF is a Nairovirus in the family Bunyaviridae, and was first described in the Crimea in 1944.  Later it was also isolated in the Congo (1969) – hence the name.

 

CCHF is normally transmitted to humans via the bite of a tick, or via contact with the blood of infected animals, although there have been reports of nosocomial (in hospital) transmission as well (see 2010  WHO report on Pakistan).

 


Today’s story isn’t so much about one rare imported case of CCHF, but about how important it is that we anticipate, and prepare for, the inevitable arrival of many more imported diseases. 

 

Which is why the CDC, along with other international public (and animal) health agencies are involved in a series of initiatives to improve global health surveillance & emergency response in this age of rising infectious diseases.  The rationale for which is explained on the CDC’s Global Health Website at:

 

Why Global Health Security Matters

Disease Threats Can Spread Faster and More Unpredictably Than Ever Before

(Excerpt)

A disease threat anywhere can mean a threat everywhere. It is defined by

  • the emergence and spread of new microbes;
  • globalization of travel and trade;
  • rise of drug resistance; and
  • potential use of laboratories to make and release—intentionally or not—dangerous microbes.

(Continue . . .)

Tuesday, March 25, 2014

WHO Director Chan: The Next New Virus Lurks . . .

image

Photo Credit WHO

 


# 8399

 

 

The World Health Organization’s Director General Margaret Chan, addressing the Credit Suisse Asian investment conference in Hong Kong yesterday, warned that - despite the fact that the world was better equipped to deal with infectious disease outbreaks than ever before - dangerous new diseases will continue to emerge, and that the pace of new emerging health threats was accelerating.


A full transcript of Director Chan’s remarks can be found at:

 

WHO Director-General addresses the Asian Investment Conference

Dr Margaret Chan

Director-General of the World Health Organization

Keynote address at the 2014 Credit Suisse
Asian Investment Conference: Are we winning the fight against infectious diseases?
Hong Kong, the People's Republic of China
24 March 2014

In this address, Director Chan addresses numerous topics, including the industrialization of food production, the threat of growing antibiotic resistance, and the potential for climate change to exacerbate the emergence of new disease threats . . . to name just a few.  


Her address is well worth reading in its entirety, but I’ve excerpted a few passages:

Today, the biggest threat from infectious diseases comes from the unknown: the next new virus lurking in the jungles of sub-Saharan Africa or in the wet markets and teeming cities of Asia.

These two geographical areas have traditionally been regarded as the breeding ground for new diseases. Around 75% of new diseases emerge following close contact between humans and domestic or wild animals. Africa and Asia offer multiple opportunities for these contacts to occur.

<snip>

A strong preference for freshly slaughtered poultry keeps the wet markets open in several parts of Asia. Most scientists view wet markets as hotspots for the emergence of new viruses that could spark the next influenza pandemic.

The practice or raising chickens near homes has been the source of numerous human cases of H5N1 infection, also among very young children who play or crawl near birds or their droppings.

All of these trends, like unprecedented population density, incursions into previously uninhabited areas, people crowded together with domestic animals, a changing climate, and the industrialization of food production, put our world on a dangerous trajectory, with new diseases just one of many prices to pay.

 

Local media coverage, as provided below by the Hong Kong Standard, understandably focused primarily on her remarks regarding the importation and sale of live poultry in the wake of the year-long outbreak of H7N9 in China. 

 

Although a temporary ban is in place, the long-term policy regarding live poultry imports remains uncertain, with many top scientists urging that the ban not be lifted.

 

This from the Hong Kong Standard.

 

WHO chief urges end to sale of live poultry

Mary Ann Benitez

Tuesday, March 25, 2014

The World Health Organization director- general Margaret Chan Fung Fu-chun is urging Hong Kong to consider banning the sale of live poultry to stop bird flu.

Speaking at a conference in the territory, Chan said that wet markets are a breeding ground for the deadly new diseases. But Chan, the territory's former director of health, said that it would be difficult to impose a ban because of the local preference for fresh chicken.

(Continue . . . )

 

 

The evidence that closing live-bird markets reduces the spread of avian flu viruses is pretty solid (see The Lancet: Poultry Market Closure Effect On H7N9 Transmission), making it an obvious mitigation strategy.  But old habits die hard; purchasing live market birds is deeply ingrained in the Chinese culture, and there has been much public resistance to closing these markets.


Which illustrates the fact that public health policies cannot be made in a scientific vacuum; that economic, political, and societal factors (which vary widely around the world) will always influence what can – and what cannot – be readily accomplished.

 

While outbreaks of exotic diseases, or the specter of a pandemic, typically garners the biggest headlines, the bulk of Director Chan’s remarks were related to the growing antibiotic resistance crisis -  which, if it continues – truly threatens a dark future for all aspects of medicine.  A few excerpts:

 

We are losing our first-line antibiotics, our miracle cures. Replacement treatments are more costly, more toxic, need much longer durations of treatment, and may require treatment in intensive care units. For some diseases, the death rate doubles when drug resistance develops.

Many common bacteria have developed resistance to multiple drugs, some to nearly all. Hospitals have become hotbeds for highly-resistant superbugs, increasing the risk that hospitals kill rather than heal. These are end-of-the-road pathogens that are resistant to last-line drugs.

If current trends continue, the future is easy to predict. Some experts say we are moving back to the pre-antibiotic era. No. This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is virtually dry, the cupboard is nearly bare.

A post-antibiotic era means, in effect, an end to modern medicine as we know it. Common infections will once again kill. Some sophisticated interventions, like hip replacements, organ transplants, cancer chemotherapy, and care of preterm infants, will become far more difficult or even too dangerous to undertake.

Even simple interventions, like surgery to treat myopia, will become too dangerous to perform.

 

While a stark prediction, in some places in the world – and with some bacterial infections – we are already there (see ECDC/WHO: World TB Day - Focus On MDR & XDR Treatment Outcomes).

 

In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully

 

For more on the spread of antibiotic resistance around the globe, you may wish to revisit:

 

EID Journal: Acquisition of Drug Resistant Genes Through International Travel
UK CMO: Antimicrobial Resistance Poses `Catastrophic Threat’
MMWR Vital Signs: Carbapenem-Resistant Enterobacteriaceae (CRE)
Chan: World Faces A `Post-Antibiotic Era’